EU supports biotech company in Austria with EUR 24 million for antifungal research and innovation

Thursday, 22 November, 2018
The European Investment Bank (EIB) is lending EUR 24 million to F2G Biotech, a research-intensive company in Austria, focusing on the discovery and development of novel drugs to treat life threatening fungal diseases.